Trial intelligence / Profile preview

Efficacy, safety and systemic effect of intra-articular and intraosseous PRP in knee osteoarthritis

2015-004738-90Phase 3Active

Sponsor
Arthroscopic Surgery Unit
Start
Jan 2016
Modality
Cell Therapies
Countries
1
01

Overview

Phase 3, randomised trial of PRGF-Endoret in knee osteoarthritis (OA), sponsored by Arthroscopic Surgery Unit. Primary endpoint: Clinically significant pain improvement (KOOS pain subscale). Started Jan 2016; status: active.

02

Drugs

PRGF-Endoret
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2015-004738-90.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-004738-90.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call